Huiying Lu

1.2k total citations · 1 hit paper
25 papers, 828 citations indexed

About

Huiying Lu is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Huiying Lu has authored 25 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Huiying Lu's work include Immune cells in cancer (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Immune Response and Inflammation (5 papers). Huiying Lu is often cited by papers focused on Immune cells in cancer (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers) and Immune Response and Inflammation (5 papers). Huiying Lu collaborates with scholars based in China, United States and Germany. Huiying Lu's co-authors include Zhanju Liu, Jian Lin, Gengfeng Li, Han Gao, Mingsong Li, Ruixin Zhu, Cui Zhang, Xiang Gao, Zhitao Li and Zili Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and ACS Applied Materials & Interfaces.

In The Last Decade

Huiying Lu

23 papers receiving 823 citations

Hit Papers

Microbiota metabolite butyrate constrains neutrophil func... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiying Lu China 14 380 273 151 102 96 25 828
Ruiqing Wu China 12 345 0.9× 350 1.3× 110 0.7× 126 1.2× 78 0.8× 19 929
Stephanie A. Bora United States 7 290 0.8× 264 1.0× 90 0.6× 104 1.0× 77 0.8× 10 866
Yaíma L. Lightfoot United States 17 440 1.2× 406 1.5× 170 1.1× 84 0.8× 139 1.4× 23 1.1k
Caiyun Ma China 8 520 1.4× 186 0.7× 136 0.9× 124 1.2× 99 1.0× 17 866
Juhi Arora United States 8 257 0.7× 271 1.0× 78 0.5× 87 0.9× 71 0.7× 13 838
Bara Sarraj United States 12 345 0.9× 303 1.1× 188 1.2× 69 0.7× 70 0.7× 12 896
Jeffrey B. Brown United States 17 346 0.9× 268 1.0× 200 1.3× 54 0.5× 180 1.9× 36 1.0k
Beáta Szebeni Hungary 16 204 0.5× 228 0.8× 150 1.0× 70 0.7× 165 1.7× 41 790
Anne P. Liao United States 9 337 0.9× 196 0.7× 116 0.8× 65 0.6× 72 0.8× 10 945
Peter Zanvit United States 14 354 0.9× 688 2.5× 125 0.8× 153 1.5× 102 1.1× 29 1.2k

Countries citing papers authored by Huiying Lu

Since Specialization
Citations

This map shows the geographic impact of Huiying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiying Lu more than expected).

Fields of papers citing papers by Huiying Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiying Lu. The network helps show where Huiying Lu may publish in the future.

Co-authorship network of co-authors of Huiying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiying Lu. A scholar is included among the top collaborators of Huiying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiying Lu. Huiying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Huiying, et al.. (2025). Two sides of the same coin: protective versus pathogenic mesentery in inflammatory bowel diseases – a comprehensive review. International Journal of Surgery. 111(11). 8349–8362.
2.
Wei, Wen‐Juan, Guiyun Wang, Ye Wang, et al.. (2025). Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs. Cardiovascular Diabetology. 24(1). 89–89.
3.
Qin, Yuxin, Huiying Lu, Yang Shu, & Jianhua Wang. (2025). Atovaquone-Coordinated Copper-Polyphenol Nanoplatform Orchestrates Dual Metabolic Interference for Synergistic Cuproptosis and Apoptosis. ACS Applied Materials & Interfaces. 17(14). 21001–21012. 4 indexed citations
4.
Wang, Jiewen, Guangbo Kang, Huiying Lu, et al.. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine. 14(3). e1636–e1636. 7 indexed citations
5.
Lu, Huiying, et al.. (2024). Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease. Biomarker Research. 12(1). 76–76. 24 indexed citations
6.
Chen, Huimin, Xiaohan Wu, Ruicong Sun, et al.. (2023). Dysregulation of CD177 + neutrophils on intraepithelial lymphocytes exacerbates gut inflammation via decreasing microbiota-derived DMF. Gut Microbes. 15(1). 2172668–2172668. 11 indexed citations
7.
Lin, Jian, Gengfeng Li, Cui Zhang, et al.. (2022). MCPIP-1-Mediated Immunosuppression of Neutrophils Exacerbates Acute Bacterial Peritonitis and Liver Injury. Journal of Innate Immunity. 15(1). 262–282. 4 indexed citations
8.
Lu, Huiying, Cui Zhang, Wei Wu, et al.. (2022). MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis. Gut. 72(5). 882–895. 37 indexed citations
9.
He, Qiong, Han Gao, Xiaohan Wu, et al.. (2022). ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP. Journal of Autoimmunity. 132. 102872–102872. 21 indexed citations
10.
Lin, Ritian, Wei Wu, Huimin Chen, et al.. (2022). GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2. Clinical and Translational Medicine. 12(3). e771–e771. 38 indexed citations
11.
Song, Lele, Renxu Chang, Xia Sun, et al.. (2021). Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Communications Biology. 4(1). 213–213. 13 indexed citations
12.
Lu, Huiying, Jian Lin, Mingming Sun, et al.. (2021). Cyclosporine modulates neutrophil functions via the SIRT6–HIF‐1α–glycolysis axis to alleviate severe ulcerative colitis. SHILAP Revista de lepidopterología. 11(2). e334–e334. 73 indexed citations
13.
Li, Gengfeng, Jian Lin, Cui Zhang, et al.. (2021). Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 13(1). 1968257–1968257. 305 indexed citations breakdown →
14.
Lin, Jian, Gengfeng Li, Huiying Lu, et al.. (2020). Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities. Mediators of Inflammation. 2020. 1–15. 15 indexed citations
15.
Lin, Ritian, Huiying Lu, Guangxi Zhou, Qing Wei, & Zhanju Liu. (2017). Clinicopathological and Ileocolonoscopic Characteristics in Patients with Nodular Lymphoid Hyperplasia in the Terminal Ileum. International Journal of Medical Sciences. 14(8). 750–757. 7 indexed citations
16.
Lu, Huiying, Ritian Lin, Guangxi Zhou, Tianming Yu, & Zhanju Liu. (2017). Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis. International Journal of Medical Sciences. 14(11). 1154–1162. 8 indexed citations
17.
Eroğlu, Yasemen, et al.. (2009). Pediatric eosinophilic esophagitis: Single‐center experience in northwestern USA. Pediatrics International. 51(5). 612–616. 13 indexed citations
18.
Martin, Tammy M., Zili Zhang, Paul A. Kurz, et al.. (2009). The NOD2 defect in Blau syndrome does not result in excess interleukin‐1 activity. Arthritis & Rheumatism. 60(2). 611–618. 74 indexed citations
19.
Zhang, Zili, David J. Hinrichs, Huiying Lu, et al.. (2006). After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?. International Immunopharmacology. 7(4). 409–416. 53 indexed citations
20.
Zeng, Xuemei, et al.. (2001). NBP is the p53 homolog p63. Carcinogenesis. 22(2). 215–219. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026